FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995367007> ?p ?o ?g. }

• W1995367007 endingPage "228" @default.
• W1995367007 startingPage "221" @default.
• W1995367007 abstract "Human NAD(P)H:quinone acceptor oxidoreductase-2 (NQO2) has been prepared using an Escherichia coli expression method. NQO2 is thought to be an isoform of DT-diaphorase (EC 1.6.99.2) [also referred to as NAD(P)H:quinone acceptor oxidoreductase] because there is a 49% identity between their amino acid sequences. The present investigation has revealed that like DT-diaphorase, NQO2 is a dimer enzyme with one FAD prosthetic group per subunit. Interestingly, NQO2 uses dihydronicotinamide riboside (NRH) rather than NAD(P)H as an electron donor. It catalyzes a two-electron reduction of quinones and oxidation-reduction dyes. One-electron acceptors, such as potassium ferricyanide, cannot be reduced by NQO2. This enzyme also catalyzes a four-electron reduction, using methyl red as the electron acceptor. The NRH-methyl red reductase activity of NQO2 is 11 times the NADH-methyl red reductase activity of DT-diaphorase. In addition, through a four-electron reduction reaction, NQO2 can catalyze nitroreduction of cytotoxic compound CB 1954 [5-(aziridin-1-yl)-2,4-dinitrobenzamide]. NQO2 is 3000 times more effective than DT-diaphorase in the reduction of CB 1954. Therefore, NQO2 is a NRH-dependent oxidoreductase which catalyzes two- and four-electron reduction reactions. NQO2 is resistant to typical inhibitors of DT-diaphorase, such as dicumarol, Cibacron blue, and phenindone. Flavones are inhibitors of NQO2. However, structural requirements of flavones for the inhibition of NQO2 are different from those for DT-diaphorase. The most potent flavone inhibitor tested so far is quercetin (3,5,7,3',4'-. 6pentahydroxyflavone). It has been found that quercetin is a competitive inhibitor with respect to NRH (Ki = 21 nM). NQO2 is 43 amino acids shorter than DT-diaphorase, and it has been suggested that the carboxyl terminus of DT-diaphorase plays a role in substrate binding (S. Chen et al., Protein Sci. 3, 51-57, 1994). In order to understand better the basis of catalytic differences between NQO2 and DT-diaphorase, a human NQO2 with 43 amino acids from the carboxyl terminus of human DT-diaphorase (i.e., hNQO2-hDT43) has been prepared. hNQO2-hDT43 still uses NRH as an electron donor. In addition, the chimeric enzyme is inhibited by quercetin but not dicumarol. These results suggest that additional region(s) in these enzymes is involved in differentiating NRH from NAD(P)H." @default.
• W1995367007 created "2016-06-24" @default.
• W1995367007 creator A5000396228 @default.
• W1995367007 creator A5000833433 @default.
• W1995367007 creator A5010709529 @default.
• W1995367007 creator A5025035318 @default.
• W1995367007 creator A5027903995 @default.
• W1995367007 creator A5042738699 @default.
• W1995367007 creator A5064649529 @default.
• W1995367007 creator A5090099645 @default.
• W1995367007 date "1997-11-01" @default.
• W1995367007 modified "2023-10-10" @default.
• W1995367007 title "Catalytic Properties of NAD(P)H:Quinone Oxidoreductase-2 (NQO2), a Dihydronicotinamide Riboside Dependent Oxidoreductase" @default.
• W1995367007 cites W1903041271 @default.
• W1995367007 cites W1914561217 @default.
• W1995367007 cites W1932522703 @default.
• W1995367007 cites W1963953060 @default.
• W1995367007 cites W1973515387 @default.
• W1995367007 cites W1990769463 @default.
• W1995367007 cites W1990927292 @default.
• W1995367007 cites W1994548752 @default.
• W1995367007 cites W1995583074 @default.
• W1995367007 cites W2002314190 @default.
• W1995367007 cites W2016055538 @default.
• W1995367007 cites W2017216637 @default.
• W1995367007 cites W2022395403 @default.
• W1995367007 cites W2054459335 @default.
• W1995367007 cites W2062444423 @default.
• W1995367007 cites W2077659237 @default.
• W1995367007 cites W2078683837 @default.
• W1995367007 cites W2094333940 @default.
• W1995367007 cites W2100837269 @default.
• W1995367007 cites W2129507265 @default.
• W1995367007 cites W2136238492 @default.
• W1995367007 cites W2401880178 @default.
• W1995367007 cites W25878943 @default.
• W1995367007 cites W87107736 @default.
• W1995367007 doi "https://doi.org/10.1006/abbi.1997.0344" @default.
• W1995367007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9367528" @default.
• W1995367007 hasPublicationYear "1997" @default.
• W1995367007 type Work @default.
• W1995367007 sameAs 1995367007 @default.
• W1995367007 citedByCount "129" @default.
• W1995367007 countsByYear W19953670072012 @default.
• W1995367007 countsByYear W19953670072013 @default.
• W1995367007 countsByYear W19953670072014 @default.
• W1995367007 countsByYear W19953670072015 @default.
• W1995367007 countsByYear W19953670072016 @default.
• W1995367007 countsByYear W19953670072017 @default.
• W1995367007 countsByYear W19953670072018 @default.
• W1995367007 countsByYear W19953670072019 @default.
• W1995367007 countsByYear W19953670072020 @default.
• W1995367007 countsByYear W19953670072021 @default.
• W1995367007 countsByYear W19953670072022 @default.
• W1995367007 countsByYear W19953670072023 @default.
• W1995367007 crossrefType "journal-article" @default.
• W1995367007 hasAuthorship W1995367007A5000396228 @default.
• W1995367007 hasAuthorship W1995367007A5000833433 @default.
• W1995367007 hasAuthorship W1995367007A5010709529 @default.
• W1995367007 hasAuthorship W1995367007A5025035318 @default.
• W1995367007 hasAuthorship W1995367007A5027903995 @default.
• W1995367007 hasAuthorship W1995367007A5042738699 @default.
• W1995367007 hasAuthorship W1995367007A5064649529 @default.
• W1995367007 hasAuthorship W1995367007A5090099645 @default.
• W1995367007 hasConcept C134651460 @default.
• W1995367007 hasConcept C181199279 @default.
• W1995367007 hasConcept C185592680 @default.
• W1995367007 hasConcept C2779268744 @default.
• W1995367007 hasConcept C2780508121 @default.
• W1995367007 hasConcept C2900893 @default.
• W1995367007 hasConcept C55493867 @default.
• W1995367007 hasConcept C71240020 @default.
• W1995367007 hasConcept C75520062 @default.
• W1995367007 hasConceptScore W1995367007C134651460 @default.
• W1995367007 hasConceptScore W1995367007C181199279 @default.
• W1995367007 hasConceptScore W1995367007C185592680 @default.
• W1995367007 hasConceptScore W1995367007C2779268744 @default.
• W1995367007 hasConceptScore W1995367007C2780508121 @default.
• W1995367007 hasConceptScore W1995367007C2900893 @default.
• W1995367007 hasConceptScore W1995367007C55493867 @default.
• W1995367007 hasConceptScore W1995367007C71240020 @default.
• W1995367007 hasConceptScore W1995367007C75520062 @default.
• W1995367007 hasIssue "2" @default.
• W1995367007 hasLocation W19953670071 @default.
• W1995367007 hasLocation W19953670072 @default.
• W1995367007 hasOpenAccess W1995367007 @default.
• W1995367007 hasPrimaryLocation W19953670071 @default.
• W1995367007 hasRelatedWork W1981759285 @default.
• W1995367007 hasRelatedWork W2007295595 @default.
• W1995367007 hasRelatedWork W2051946731 @default.
• W1995367007 hasRelatedWork W2061661215 @default.
• W1995367007 hasRelatedWork W2080331064 @default.
• W1995367007 hasRelatedWork W2176536151 @default.
• W1995367007 hasRelatedWork W2400672345 @default.
• W1995367007 hasRelatedWork W2411121931 @default.
• W1995367007 hasRelatedWork W4245240558 @default.
• W1995367007 hasRelatedWork W955209252 @default.
• W1995367007 hasVolume "347" @default.

• next